(Q33895875)

29 July 2017

title

Priorities for screening and treatment of latent tuberculosis infection in the United States (English)

1 reference

29 July 2017

0 references

1 reference

United States of America

1 reference

1

Benjamin P Linas

1 reference

29 July 2017

3

Kenneth A Freedberg

1 reference

29 July 2017

Angela Y Wong

2

1 reference

29 July 2017

C Robert Horsburgh

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 September 2011

1 reference

American Journal of Respiratory and Critical Care Medicine

29 July 2017

published in

1 reference

29 July 2017

volume

184

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

590-601

1 reference

Birth cohort effect on latent tuberculosis infection prevalence, United States

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Revisiting rates of reactivation tuberculosis: a population-based approach

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Economic costs of diabetes in the U.S. In 2007.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Cost-effectiveness of digital mammography breast cancer screening

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Long-term mortality after gastric bypass surgery

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Pulmonary adverse events of anti-tumor necrosis factor-alpha antibody therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Excess deaths associated with underweight, overweight, and obesity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

What is the price of life and why doesn't it increase at the rate of inflation?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Outcomes of contact investigations of infectious tuberculosis patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Causes and costs of hospitalization of tuberculosis patients in the United States

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

A tuberculin screening and isoniazid preventive therapy program in an inner-city population

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Results of screening for tuberculosis in foreign-born persons applying for adjustment of immigration status

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Epidemiological basis of tuberculosis eradication. 10. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Controlled chemoprophylaxis trials in tuberculosis. A general review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Tuberculosis in a Cohort of Southeast Asian Refugees: A Five-Year Surveillance Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of BCG vaccination

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Drug Dependence, A Possible New Risk Factor for Tuberculosis Disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

5 July 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Tuberculosis and substance abuse in the United States, 1997-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

QuantiFERON-TB Gold in the diagnosis of active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Measurement of health preferences among patients with tuberculous infection and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Feasibility and reliability of health-related quality of life measurements among tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Injection drug users in the United States, 1979-2002: an aging population

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Trends in bariatric surgical procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Tuberculosis among foreign-born persons in the United States: achieving tuberculosis elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Cost-effectiveness of colonoscopy in screening for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Mortality trends in men and women with diabetes, 1971 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Mathematical model for the epidemiology of tuberculosis, with estimates of the reproductive number and infection-delay function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

HIV prevalence estimates--United States, 2006.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175546

Priorities for the Treatment of Latent Tuberculosis Infection in the United States

29 October 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0181OC

Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis

21 January 2018

1 reference

12 December 2020

Tuberculosis screening in alcoholics and drug addicts

1 reference

12 December 2020

Tuberculosis screening in alcoholics and drug addicts

1 reference

12 December 2020

A cost-effectiveness analysis of the routine use of isoniazid prophylaxis in patients with a positive Mantoux skin test

1 reference

12 December 2020

Mortality in a cohort of homeless adults in Philadelphia

1 reference

12 December 2020

Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic

1 reference

12 December 2020

Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts

1 reference

12 December 2020

The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis

1 reference

12 December 2020

Transmission of tuberculosis in San Francisco and its association with immigration and ethnicity

1 reference

12 December 2020

Benefits of screening for latent Mycobacterium tuberculosis infection

1 reference

12 December 2020

The cost-effectiveness of screening for latent tuberculosis infection

1 reference

12 December 2020

Changes in the transmission of tuberculosis in New York City from 1990 to 1999

1 reference

12 December 2020

Treatment for latent TB in correctional facilities: a challenge for TB elimination

1 reference

12 December 2020

BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life

1 reference

12 December 2020

10.1164/RCCM.201101-0181OC

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference